HomeCompareRGTPQ vs XYLD

RGTPQ vs XYLD: Dividend Comparison 2026

RGTPQ yields 1250.00% · XYLD yields 10.98%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RGTPQ wins by $135327077.56M in total portfolio value
10 years
RGTPQ
RGTPQ
● Live price
1250.00%
Share price
$0.16
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$135327077.59M
Annual income
$116,926,161,071,848.38
Full RGTPQ calculator →
XYLD
Global X S&P 500 Covered Call ETF
● Live price
10.98%
Share price
$39.13
Annual div
$4.30
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.3K
Annual income
$3,219.02
Full XYLD calculator →

Portfolio growth — RGTPQ vs XYLD

📍 RGTPQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRGTPQXYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RGTPQ + XYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RGTPQ pays
XYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RGTPQ
Annual income on $10K today (after 15% tax)
$106,250.00/yr
After 10yr DRIP, annual income (after tax)
$99,387,236,911,071.11/yr
XYLD
Annual income on $10K today (after 15% tax)
$933.63/yr
After 10yr DRIP, annual income (after tax)
$2,736.17/yr
At 15% tax rate, RGTPQ beats the other by $99,387,236,908,334.94/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RGTPQ + XYLD for your $10,000?

RGTPQ: 50%XYLD: 50%
100% XYLD50/50100% RGTPQ
Portfolio after 10yr
$67663538.81M
Annual income
$58,463,080,537,533.70/yr
Blended yield
86.40%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RGTPQ buys
0
XYLD buys
0
No recent congressional trades found for RGTPQ or XYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRGTPQXYLD
Forward yield1250.00%10.98%
Annual dividend / share$2.00$4.30
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$135327077.59M$25.3K
Annual income after 10y$116,926,161,071,848.38$3,219.02
Total dividends collected$133960810.96M$19.6K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: RGTPQ vs XYLD ($10,000, DRIP)

YearRGTPQ PortfolioRGTPQ Income/yrXYLD PortfolioXYLD Income/yrGap
1← crossover$135,700$125,000.00$10,818$1,098.39+$124.9KRGTPQ
2$1,730,479$1,585,280.37$11,738$1,222.51+$1.72MRGTPQ
3$20,744,959$18,893,346.29$12,774$1,364.64+$20.73MRGTPQ
4$233,872,934$211,675,827.14$13,944$1,527.86+$233.86MRGTPQ
5$2,480,500,804$2,230,256,765.05$15,270$1,715.87+$2480.49MRGTPQ
6$24,761,170,753$22,107,034,892.35$16,775$1,933.09+$24761.15MRGTPQ
7$232,737,122,500$206,242,669,794.36$18,490$2,184.87+$232737.10MRGTPQ
8$2,060,741,008,119$1,811,712,287,044.72$20,450$2,477.63+$2060740.99MRGTPQ
9$17,197,118,239,637$14,992,125,360,949.39$22,697$2,819.19+$17197118.22MRGTPQ
10$135,327,077,588,260$116,926,161,071,848.38$25,280$3,219.02+$135327077.56MRGTPQ

RGTPQ vs XYLD: Complete Analysis 2026

RGTPQStock

RegenETP, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and other tissue regeneration products. The company was formerly known as PolarityTE, Inc. and changed its name to RegenETP, Inc. in August 2023. RegenETP, Inc. is headquartered in Salt Lake City, Utah.

Full RGTPQ Calculator →

XYLDETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →
📬

Get this RGTPQ vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RGTPQ vs SCHDRGTPQ vs JEPIRGTPQ vs ORGTPQ vs KORGTPQ vs MAINRGTPQ vs QYLDRGTPQ vs JEPQRGTPQ vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.